Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace

Maren Heimhalt, Alex Berndt, Jane Wagstaff, Madhanagopal Anandapadamanaban, Olga Perisic, Sarah Maslen, Stephen McLaughlin, Conny Wing Heng Yu, Glenn R. Masson, Andreas Boland, Xiaodan Ni, Keitaro Yamashita, Garib N. Murshudov, Mark Skehel, Stefan M. Freund, Roger L. Williams (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)

    Abstract

    The mTORC1 kinase complex regulates cell growth, proliferation, and survival. Because mis-regulation of DEPTOR, an endogenous mTORC1 inhibitor, is associated with some cancers, we reconstituted mTORC1 with DEPTOR to understand its function. We find that DEPTOR is a unique partial mTORC1 inhibitor that may have evolved to preserve feedback inhibition of PI3K. Counterintuitively, mTORC1 activated by RHEB or oncogenic mutation is much more potently inhibited by DEPTOR. Although DEPTOR partially inhibits mTORC1, mTORC1 prevents this inhibition by phosphorylating DEPTOR, a mutual antagonism that requires no exogenous factors. Structural analyses of the mTORC1/DEPTOR complex showed DEPTOR’s PDZ domain interacting with the mTOR FAT region, and the unstructured linker preceding the PDZ binding to the mTOR FRB domain. The linker and PDZ form the minimal inhibitory unit, but the N-terminal tandem DEP domains also significantly contribute to inhibition.

    Original languageEnglish
    Article numbere68799
    Number of pages38
    JournaleLife
    Volume10
    DOIs
    Publication statusPublished - 14 Sept 2021

    ASJC Scopus subject areas

    • General Neuroscience
    • General Biochemistry,Genetics and Molecular Biology
    • General Immunology and Microbiology

    Fingerprint

    Dive into the research topics of 'Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace'. Together they form a unique fingerprint.

    Cite this